The serotonin transporter (SERT) belongs to a family of sodium chloride-dependent transporters responsible for uptake of amino acids and biogenic amines from extracellular spaces. SERT represents the main pharmacological target in the treatment of several clinical conditions, including depression and anxiety. Serotonin-selective reuptake inhibitors and tricyclic antidepressants are the most predominantly prescribed drugs in the treatment of depression. In addition to antidepressants also psychostimulants, like cocaine and amphetamines, are important SERT antagonists. In the present study, we report the cloning and characterization of chicken SERT. Although the uptake kinetic was very similar to human SERT, the pharmacological profiles differed considerably for the two species. We find that chicken SERT is capable of discriminating between different serotonin-selective reuptake inhibitors; thus, the potency of S-citalopram and paroxetine is reduced more than 40-fold. A cross-species chimera strategy was undertaken and followed by species-scanning mutagenesis. Differences in pharmacological profiles were tracked to amino acid residues 169, 172, and 586 in human SERT. Structure-activity studies on structurally related compounds indicated that species divergences in drug sensitivity between human and chicken SERT were arising from differences in coordination or recognition of an important aminomethyl pharmacophoric substructure, which is shared by all high affinity antidepressants. Consequently, we suggest that Ala 169 and Ile 172 of human SERT are important residues in sensing the N-methylation state of SERT antagonists.Serotonergic neurotransmission is modulated by active reuptake of serotonin (5-hydroxytryptamine or 5-HT) 1 from the extracellular space. Reuptake is mediated by the serotonin transporter (SERT), and 5-HT is subsequently either degraded by monoamine oxidases or repackaged into vesicles by the proton-dependent vesicular monoamine transporter. A balance between release and active reuptake of 5-HT determines the magnitude and duration of signaling and thus plays a key role in the spatio-temporal fine tuning of serotonergic neurotransmission.Malfunction in active 5-HT reuptake is speculated to be associated with psychiatric disorders, particularly anxiety and depression (1, 2). Antidepressants inhibiting 5-HT reuptake are used also in treatment of anxiety disorders, obsessivecompulsive disorders, and eating disorders (3, 4).SERT is a member of a large family of homologous integral membrane proteins (5). SERT is of considerable interest as a molecular target for many antidepressants, including the tricyclic antidepressants such as imipramine and amitriptyline, as well as the serotonin-selective reuptake inhibitors (SSRIs) like citalopram, fluoxetine, paroxetine, sertraline, and fluvoxamine. SERT is also target for drugs of abuse including cocaine and amphetamines such as 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") (6, 7).SERT is a putative 12-transmembrane (TM) domain protein that co-transports...